Delivery Order SPE2DB20D3103-SPE2DB22FN5H6
- Not listed
- This federal contract award is a delivery order valued at $3,234.04 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Lidocaine 5% Patches and has a period of performance through October 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
- This federal contract award is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,285.72 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 4, 2023, with a completion date of May 5, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for providing a...
- This federal contract award is for the delivery of Lidocaine 5% patches to the Defense Logistics Agency (DLA). The contract, valued at $5,152.35, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, and the ultimate completion date is June 7, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of Lidocaine 5% Patch 30s to the Defense Logistics Agency (DLA). The $2,561.63 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a total completion date of July 16, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which covers a...
- This contract award is for the delivery of lidocaine 5% patches to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The firm-fixed-price delivery order has a ceiling value of $1,675.84 and a completion date of December 12, 2024. The contract is not designated with a set-aside requirement, indicating open competition....
- This federal contract award is for the delivery of Lidocaine 5% patch prescriptions to the Defense Logistics Agency (DLA). The $8,384.36 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of May 23, 2023 and was awarded on May 22, 2023. This delivery order is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of Lidocaine 5% Patches to the Defense Logistics Agency (DLA). The contract, valued at $2,234.59, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for providing a comprehensive...
- This federal contract award is for the delivery of Lidocaine 5% patches to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $2,714.96, was made to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of December 26, 2023. The award is not designated as a set-aside contract. Amerisourcebergen holds...
- This federal contract award is for the delivery of Lidocaine 5% patches to the Defense Logistics Agency (DLA). The prime contractor is AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $6,657.94 and an ultimate completion date of October 21, 2024. The contract is not set aside for any special designation. AmerisourceBergen holds a broader Indefinite Delivery Contract (IDC) with the...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,937.47 firm fixed-price delivery order is for the supply of 4560957153 - Lidocaine 5% Patch 30s, with a completion date of May 17, 2023. The contract is not designated under any set-aside program. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FN5H6Delivery Order
This federal contract award is for the delivery of Lidocaine 5% patch products to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $3,462.58, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has a performance period through November 2026. This specific delivery order does not have a set-aside designation, indicating open competition. The contract supports the medical needs of military personnel, veterans, and other federal beneficiaries through a streamlined procurement mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 5/4/22 |